Serge Pinto
Overview
Explore the profile of Serge Pinto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
641
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pinto S, Cardoso R, Atkinson-Clement C, Guimaraes I, Sadat J, Santos H, et al.
J Speech Lang Hear Res
. 2024 May;
67(9):2822-2841.
PMID: 38754039
Purpose: Cross-language studies suggest more similarities than differences in how dysarthria affects the speech of people with Parkinson's disease (PwPD) who speak different languages. In this study, we aimed to...
2.
Goldman J, Volpe D, Ellis T, Hirsch M, Johnson J, Wood J, et al.
J Parkinsons Dis
. 2024 Jan;
14(1):135-166.
PMID: 38277303
Background: Parkinson's disease (PD) is a complex neurodegenerative disorder impacting everyday function and quality of life. Rehabilitation plays a crucial role in improving symptoms, function, and quality of life and...
3.
Thies T, Jergas H, Mucke D, Brandt G, Visser-Vandewalle V, Pinto S, et al.
Brain Stimul
. 2024 Jan;
16(6):1598-1600.
PMID: 38193255
No abstract available.
4.
Cuartero M, Grabli D, Flamand-Roze E, Karachi C, Rouaud T, Derkinderen P, et al.
Brain Stimul
. 2024 Jan;
17(1):104-106.
PMID: 38182095
No abstract available.
5.
Gessani A, Cavallieri F, Fioravanti V, Campanini I, Merlo A, Di Rauso G, et al.
Sci Rep
. 2023 Aug;
13(1):13399.
PMID: 37591892
No abstract available.
6.
Cavallieri F, Di Rauso G, Gessani A, Budriesi C, Fioravanti V, Contardi S, et al.
Front Neurol
. 2023 Aug;
14:1213772.
PMID: 37533469
Background: Very few studies have assessed the presence of a possible correlation between speech variables and limb bradykinesia in patients with Parkinson's disease (PD). The objective of this study was...
7.
Gessani A, Cavallieri F, Fioravanti V, Campanini I, Merlo A, Di Rauso G, et al.
Sci Rep
. 2023 Jul;
13(1):11462.
PMID: 37454168
Bilateral subthalamic nucleus deep brain stimulation (STN-DBS) is an effective treatment in advanced Parkinson's Disease (PD). However, the effects of STN-DBS on speech are still debated, particularly in the long-term...
8.
Cavallieri F, Gessani A, Merlo A, Campanini I, Budriesi C, Fioravanti V, et al.
Eur J Neurol
. 2023 Mar;
30(7):1963-1972.
PMID: 36971736
Objective: To evaluate correlations between speech and gait parameters in the long term and under different medication and subthalamic nucleus deep brain stimulation (STN-DBS) conditions in a cohort of advanced...
9.
Marchetti R, Pinto S, Spieser L, Vaugoyeau M, Cavalli E, El Ahmadi A, et al.
Brain Sci
. 2023 Feb;
13(2).
PMID: 36831753
Phonemic processing skills are impaired both in children and adults with dyslexia. Since phoneme representation development is based on articulatory gestures, it is likely that these gestures influence oral reading-related...
10.
Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease
Pinto S, Nebel A, Rau J, Espesser R, Maillochon P, Niebuhr O, et al.
Mov Disord
. 2022 Dec;
38(2):212-222.
PMID: 36461899
Background: The EARLYSTIM trial demonstrated for Parkinson's disease patients with early motor complications that deep brain stimulation of the subthalamic nucleus (STN-DBS) and best medical treatment (BMT) was superior to...